New drug hope for rare Heart-Lung condition: sotatercept trial launches
Disease control
Recruiting now
This study tests whether adding the drug sotatercept to standard care can help adults with pulmonary arterial hypertension (PAH) caused by unrepaired congenital heart defects, including Eisenmenger syndrome. About 36 adults in Japan will be randomly assigned to receive either sot…
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated May 26, 2026 12:03 UTC